PharmaNutra SpA (CHIX:PHNM) Total Deposits

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:PHNM PharmaNutra SpA CHIX:PHNM
87 GF Score
Price €77.25
GF Value €82.00
! 2 Warning Signs
View Full Analysis

What is PharmaNutra SpA Total Deposits?

Total Deposits only applies to banks.

CHIX:PHNM
87GF Score
PharmaNutra SpA CHIX:PHNM
Total Deposits is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is PharmaNutra SpA (CHIX:PHNM) Overvalued in 2026?

Based on GuruFocus' analysis, PharmaNutra SpA stock appears to be undervalued. The current stock price of €77.25 is trading 5.8% below its estimated GF Value™ of €82.00.

Key valuation signals for CHIX:PHNM:

  • Total Deposits:
  • GF Value™: €82.00 vs. price of €77.25 (5.8% below fair value)
  • GF Score™: 87/100 with 2 warning signs

No single metric tells the full story. See the CHIX:PHNM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PharmaNutra SpA Business Description

Other Exchanges PHN:Italy761:Germany
Address Via Campodavela 1, Pisa, ITA, 56122
PharmaNutra SpA is an Italian pharmaceutical and nutraceutical company that researches, develops, and markets nutritional supplements and medical devices. Its portfolio is built around proprietary mineral-delivery technologies, including Sucrosomial iron used in its SiderAL line of iron supplements, and products such as UltraMag magnesium, Cetilar for muscle and joint support, and Apportal. The company sells through pharmacies and parapharmacies, primarily in Italy, and also operates in other European countries and select international markets across the Middle East, the Americas, and Asia. Revenue comes mainly from sales of branded consumer health products, supported by clinical research and patents that differentiate its formulations. PharmaNutra also conducts contract research and manufacturing activities through its subsidiaries, complementing its core supplement business.
87GF Score

Get the complete analysis for CHIX:PHNM

Total Deposits is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€77.25
Price
€82.00
GF Value